Casi Pharmaceuticals

(NASDAQ) CASI

Current PriceN/A

Market CapN/A

Since IPO (1996)-100%

5 Year-100%

1 Year-100%

1 Month-100%

Casi Pharmaceuticals Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$26.85M

Net Income (TTM)

-$49.38M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

Mar 30, 2026

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Estimated Earnings Date

Mar 30, 2026

CASI News

5 More Top Small Caps

Tim HansonOct 27, 2006

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Casi Pharmaceuticals

Industry

Biotechnology

Sector

Health Care

Headquarters

Beijing, MD 20850, US

CASI Financials

Key Financial Metrics (TTM)

Gross Margin

35.80%

Operating Margin

-167.98%

Net Income Margin

-183.93%

Return on Equity

358.32%

Return on Capital

-165.14%

Return on Assets

-201.86%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$9.61M

Operating Income

-$45.10M

EBITDA

-$40.47M

Operating Cash Flow

$0.00

Capital Expenditure

$0.00

Free Cash Flow

$0.00

Cash & ST Invst.

$4.69M

Total Debt

$18.86M

Casi Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

Q3 2025YOY CHG

Revenue

$3.08M

-60.5%

Gross Profit

$706.00K

-82.5%

Gross Margin

22.96%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

233

N/A

Net Income

-$10.88M

-29.6%

EBITDA

-$10.11M

-41.3%

Quarterly Fundamentals

Name

Q3 2025YOY CHG

Total Cash

$4.69M

-77.5%

Total Debt

$18.86M

-1.4%

Accounts Receivable

$2.61M

-76.6%

Inventory

$2.61M

-79.8%

Long Term Debt

$0.00

-100.0%

Short Term Debt

$18.86M

N/A

Return on Assets

-2.02%

N/A

Return on Invested Capital

3.01%

N/A

Free Cash Flow

$0.00

N/A

Operating Cash Flow

$0.00

N/A

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

CLSDClearside Biomedical, Inc.

CLSDClearside Biomedical, Inc.$0.41+0.00%

CINGCingulate Inc.

CINGCingulate Inc.$4.83-2.23%

ENTOEntero Therapeutics, Inc.

ENTOEntero Therapeutics, Inc.$2.85-5.00%

CRISCuris, Inc.

CRISCuris, Inc.$0.36-15.49%

NCNANuCana plc

NCNANuCana plc$1.73-5.21%

PALIPalisade Bio, Inc.

PALIPalisade Bio, Inc.$1.94+5.43%

ALLRAllarity Therapeutics, Inc.

ALLRAllarity Therapeutics, Inc.$1.32-2.94%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.70-0.05%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$74.44-0.10%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.56+0.10%

FFord Motor Company

FFord Motor Company$14.00-0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$11.82-0.12%

KEELKeel Infrastructure

KEELKeel Infrastructure$6.60-0.01%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.22+0.08%

Questions About CASI

What is the current price of Casi Pharmaceuticals?

Casi Pharmaceuticals is trading at N/A per share.

What is the 52-week range for Casi Pharmaceuticals?

Over the past 52 weeks, Casi Pharmaceuticals has traded between N/A and N/A.

How much debt does Casi Pharmaceuticals have?

Casi Pharmaceuticals total debt is unavailable.

How much cash does Casi Pharmaceuticals have on hand?

Casi Pharmaceuticals does not have cash on hand data available.

What is Casi Pharmaceuticals’s dividend yield?

Casi Pharmaceuticals does not currently have a dividend yield.

Casi Pharmaceuticals

Casi Pharmaceuticals Financials at a Glance

CASI News

Why CASI Pharmaceuticals Is Crashing Today

Why CASI Pharmaceuticals Inc. Is Rocketing Higher Today

Here's Why CASI Pharmaceuticals Rose as Much as 31.6% Today

Can These Top-Performing Biotech Stocks Keep Climbing?

What Stocks Perform Well in the Midst of a Trade War?

Here's Why CASI Pharmaceuticals Rose as Much as 23.4% Today

7 Surprising 5-Star Stocks

5 More Top Small Caps

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Casi Pharmaceuticals

CASI Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Casi Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CASI

What is the current price of Casi Pharmaceuticals?

What is the 52-week range for Casi Pharmaceuticals?

How much debt does Casi Pharmaceuticals have?

How much cash does Casi Pharmaceuticals have on hand?

What is Casi Pharmaceuticals’s dividend yield?

Premium Investing Services